CLINICAL_TRIALS
trial_result
· 2018-10-03
Clinical Trial Update: A Study of Evacetrapib in Participants With Abnormal Cholesterol [Phase 1]
Summary
Phase 1 clinical trial update for evacetrapib in participants with dyslipidemia; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Dyslipidemia | Phase 1 | Status: COMPLETED | Results posted: 2018-10-03